reference/5397345

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5397345

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	667
issn	2573-9832
issueIdentifier	11
pageRange	653-667
publicationName	FASEB BioAdvances
startingPage	653
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2e601623d66bc7410686a4993f02eb70 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation	Roy KR, Uddin MB, Roy SC, Hill RA, Marshall J, Li Y, Chamcheu JC, Lu H, Liu Y. Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation. FASEB BioAdvances. 2020 Sep 02;2(11):653–67. doi: 10.1096/fba.2020-00044.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c78978bc50037b909285740264214511 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d75ff46035e912b848cc66a20d85809 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15f1c3170c3feb7363867e4e18f7d7a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c5dd1eff8e8c7783def92dcf0f823d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00bff7e7dfd63839b8ce272e46c664e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d803751f66ef3f409c58c67cdcbecc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1de4bd5db4b2ff7e08c450a6db4765e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fa0b2cc985bb5e3e50e928e4af156d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6808e81701f4aeb731602f45b1d66d60
date	2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7655095 https://doi.org/10.1096/fba.2020-00044 https://pubmed.ncbi.nlm.nih.gov/33205006
isPartOf	https://portal.issn.org/resource/ISSN/2573-9832 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/47957
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.4.1.80 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0cd62c2f54b450dbb0557c48165600e7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d1a547eaf6f4cf11fcfbfe8cd861c0c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID52931256 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d22a3a7eb3f5ed972f4761ed5322e5a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66616222 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_65b0a8b26a618de66dfdea189cab0945 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78ded0e9bfc02dc0b4484fe076924aab http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8d304c86dfe0b8e23510a970edced37

Total number of triples: 47.